GFP
CVS icon

Gryphon Financial Partners’s CVS Health CVS Stock Holding History

Gryphon Financial Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Buy
6,586
+3,621
+122% +$323K 0.06% 194
2026
Q1 		$213K Buy
+2,965
New +$228K 0.02% 342
2024
Q4 		– Sell
-4,198
Closed -$264K – 260
2024
Q3 		$264K Buy
4,198
+145
+4% +$8.46K 0.04% 251
2024
Q2 		$239K Sell
4,053
-1,025
-20% -$64.1K 0.04% 246
2024
Q1 		$405K Sell
5,078
-3,073
-38% -$235K 0.07% 182
2023
Q4 		$654K Buy
8,151
+2,653
+48% +$189K 0.12% 122
2023
Q3 		$384K Sell
5,498
-188
-3% -$13.3K 0.09% 116
2023
Q2 		$393K Sell
5,686
-548
-9% -$39K 0.09% 122
2023
Q1 		$463K Sell
6,234
-360
-5% -$30.2K 0.11% 106
2022
Q4 		$614K Sell
6,594
-1,063
-14% -$103K 0.15% 82
2022
Q3 		$730K Buy
7,657
+2,218
+41% +$220K 0.18% 64
2022
Q2 		$504K Buy
5,439
+318
+6% +$31K 0.12% 98
2022
Q1 		$518K Buy
5,121
+37
+0.7% +$3.89K 0.11% 107
2021
Q4 		$525K Buy
5,084
+99
+2% +$9.15K 0.1% 121
2021
Q3 		$424K Sell
4,985
-142
-3% -$11.9K 0.09% 120
2021
Q2 		$381K Sell
5,127
-2
-0% -$164 0.09% 126
2021
Q1 		$386K Buy
5,129
+112
+2% +$8.16K 0.09% 122
2020
Q4 		$343K Buy
5,017
+262
+6% +$17K 0.09% 117
2020
Q3 		$278K Buy
+4,755
New +$296K 0.08% 126
2020
Q2 		– Sell
-4,196
Closed -$249K – 140
2020
Q1 		$249K Buy
4,196
+39
+0.9% +$2.6K 0.09% 120
2019
Q4 		$308K Sell
4,157
-19
-0.5% -$1.33K 0.08% 134
2019
Q3 		$264K Buy
+4,176
New +$247K 0.08% 138
2018
Q3 		– Sell
-491
Closed -$32K – 305
2018
Q2 		$32K Buy
491
+104
+27% +$6.85K 0.01% 301
2018
Q1 		$24K Sell
387
-148
-28% -$10.6K 0.01% 352
2017
Q4 		$39K Buy
+535
New +$38.9K 0.02% 290

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gryphon Financial Partners's CVS Position: Q2 2026 in Review

Gryphon Financial Partners increased its CVS Health (CVS) stake by 122% in Q2 2026, buying an estimated $323K and bringing the position to 6,586 shares worth $681K. The position accounts for 0.06% of the portfolio, ranked #194.

Gryphon Financial Partners first reported a position in CVS in Q4 2017 and has held it in 25 quarters since. The position peaked at $730K in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Gryphon Financial Partners held 6,586 shares of CVS Health worth $681K as of Q2 2026.
  • Gryphon Financial Partners bought 3,621 CVS Health shares in Q2 2026, an estimated $323K.
  • CVS Health made up 0.06% of Gryphon Financial Partners's portfolio in Q2 2026, its #194 holding.
  • Gryphon Financial Partners first reported a position in CVS Health in Q4 2017 and has held it in 25 quarters since.
  • Gryphon Financial Partners's CVS Health position peaked at $730K in Q3 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.